Low risk of hypoglycemia and high efficacy of gliclazide MB: results of recent studies
Sulfonylureas are widely prescribed all over the world, mainly because of their high effectiveness. At the same time, the heterogeneity of the group is obvious, primarily in relation to the effect of drugs on the risk of developing hypoglycemic events. The review presents the results of new studies,...
Guardado en:
Autores principales: | I. V. Kononenko, O. M. Smirnova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1cedd6659ae54643b631cefee6a10323 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current data on the effectiveness of gliclazide and molecular mechanisms of action of the drug
por: Nina A. Petunina, et al.
Publicado: (2020) -
Barriers for efficacious hypoglycemic therapy in clinical practice (results of the Dialogue study)
por: Irina Evgen'evna Sapozhnikova, et al.
Publicado: (2010) -
EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2013) -
A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
por: Yury Shavkatovich Khalimov, et al.
Publicado: (2011) -
Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011)